Search Results for: astellas

Recent stem cell pubs & news: reprogramming, chromatin, single-cell, Astellas, & more

stem-cell-news-pigs-organ-transplants

What new papers and news in the stem cell sphere caught your eye? Here are some recent items that seem notable to me. Diabetes relief in mice by glucose-sensing insulin-secreting human α-cells. This paper reports cellular reprogramming to insulin-producing cells in mice. They reprogrammed α-cells with Pdx1 and MafA proteins. ‘Mitophagy inhibits amyloid-β and tau pathology and reverses …

Recent stem cell pubs & news: reprogramming, chromatin, single-cell, Astellas, & more Read More »

Stem cell news bites: Astellas trial, cystic fibrosis claim, a few cool papers

Matoba-et-al-Figure-2c-2018

Stem cell news is always burbling up, sometimes right there in front of us on the web and other times via networks of people. Astellas news. Some may remember there used to be this pioneering stem cell biotech called ACT, which then became Ocata, and finally was acquired by the big company Astellas. One of …

Stem cell news bites: Astellas trial, cystic fibrosis claim, a few cool papers Read More »

Brief update from Bob Lanza on Astellas stem cell program

Lanza-Astellas

Late in 2015, one of the pioneering stem cell and regenerative medicine biotechs, Ocata Therapeutics (fka as ACT or Advanced Cell Technology) was acquired by Astellas Pharma. At the time of purchase, Ocata had a number of areas of focus, but was most closely followed for its development of human embryonic stem cell-based retinal pigmented epithelial …

Brief update from Bob Lanza on Astellas stem cell program Read More »

What is Astellas Pharma, the purchaser of Ocata?

Fish-eating-fish

Astellas Pharma is on track to purchase Ocata Therapeutics (formerly Advanced Cell Technology). This has stirred a lot of strong feelings amongst investors in Ocata. (Update, now almost 5 years later, the Ocata vision program is still not going full steam ahead at its new owner it seems). I’ve also been wondering what exactly is …

What is Astellas Pharma, the purchaser of Ocata? Read More »

Brief quote from Bob Lanza on Ocata acquisition by Astellas

Robert-Lanza

I asked Ocata CSO, Bob Lanza, for a comment on the big news of the acquisition of the company by Astellas. Here’s what he had to say: “I can say that this is an exciting time for regenerative medicine.  The merger should greatly accelerate the pace of discovery, and, I hope, lead to treatments for …

Brief quote from Bob Lanza on Ocata acquisition by Astellas Read More »

Ocata bought by Astellas of Japan: initial perspectives on end of an era

Astellas

Bombshell news in the stem cell field as Ocata Therapeutics (OCAT; formerly Advanced Cell Technology or ACT) is reportedly to be acquired by Astellas Pharma, Inc. The offer for purchase of OCAT will be $8.50/share or almost $380 million. For more details see this detailed PDF from Astellas. This quote on the deal form Ocata: “Paul …

Ocata bought by Astellas of Japan: initial perspectives on end of an era Read More »

Startup Clade from CRISPR Therapeutics founder pursues cloaked stem cells for cancer therapy

Chad-Cowan CRISPR Therapeutics

CRISPR Therapeutics has been pursuing the idea of using gene-editing to make universally compatible stem cells for some time, but there’s an new development in this space. The potential here is big. What if you could make cloaked stem cells that could be used to produce cellular therapies that could be given to most patients …

Startup Clade from CRISPR Therapeutics founder pursues cloaked stem cells for cancer therapy Read More »

24 cell therapy & stem cell stocks I’m following

stem cell stocks

Stem cell stocks, meaning cellular therapy biotech companies, face many challenges, but their clinical research is crucial. These biotechs have ups and downs, sometimes at the same time. This is kind of the standard of “life” as any biotech company. It is definitely the case in the volatile stem cell and cell therapy arena. Today …

24 cell therapy & stem cell stocks I’m following Read More »

Recommended reads: Bee brain, COVID, from Russia with stem cells, pubs

Reprogramming-roadmap-reveals-route-to-human-induced-trophoblast-stem-cells

Reading to them was one of my favorite things to do with my kids when they were little, but it’s a long way from Goodnight Moon to this week’s list of recommended reads, although “bee brain” may have got their attention. Please take a minute to complete our The Niche reader survey for a chance …

Recommended reads: Bee brain, COVID, from Russia with stem cells, pubs Read More »

Recommended regenerative medicine reads plus COVID-19 stem cell hype

Universal-Cells

Despite the COVID-19 pandemic there are still some research things we can do including data analysis as well as reading new papers and media articles on science, including regenerative medicine. If the weather’s good and you have wi-fi (or you print articles still on paper) you can even do this out in the fresh air …

Recommended regenerative medicine reads plus COVID-19 stem cell hype Read More »